NuLegacy Gold Corporation (NULGF)
OTHER OTC:NULGF
Holding NULGF?
Track your performance easily

NuLegacy Gold (NULGF) Income Statement

20 Followers

NuLegacy Gold Income Statement

Last quarter (Q4 2024), NuLegacy Gold's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, NuLegacy Gold's net income was C$-204.00K. See NuLegacy Gold’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
C$ -38.46K---C$ 81.95KC$ 74.61K
Gross Profit
C$ 38.46K---C$ -81.95KC$ -74.61K
Operating Expense
C$ 1.23MC$ 1.52MC$ 1.86MC$ 2.41MC$ 2.36MC$ 2.04M
Operating Income
C$ -1.23MC$ -1.52MC$ -1.86MC$ -2.41MC$ -2.44MC$ -2.11M
Net Non Operating Interest Income Expense
C$ 6.69KC$ 8.40KC$ 241.00C$ 120.00C$ 76.00C$ 422.00
Other Income Expense
C$ -68.55KC$ -65.84K-C$ -28.85KC$ -962.08KC$ 299.14K
Pretax Income
C$ -1.12MC$ -1.46MC$ -1.49MC$ -2.18MC$ -3.40MC$ -1.81M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -1.12MC$ -1.46MC$ -1.49MC$ -2.18MC$ -3.40MC$ -1.81M
Basic EPS
----C$ -0.01C$ -0.01
Diluted EPS
----C$ -0.01C$ -0.01
Basic Average Shares
C$ 2.47BC$ 605.15MC$ 588.85MC$ 588.85MC$ 493.77MC$ 354.99M
Diluted Average Shares
C$ 2.47BC$ 605.15MC$ 588.85MC$ 588.85MC$ 493.77MC$ 354.99M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 121.32KC$ 129.75K
Total Expenses
C$ 1.19MC$ 1.52MC$ 1.86M-C$ 2.44MC$ 2.11M
Interest Expense
------
Net Income From Continuing And Discontinued Operation
C$ -1.12MC$ -1.46MC$ -1.49MC$ -2.18MC$ -3.40MC$ -1.81M
Normalized Income
C$ -945.52KC$ -1.14MC$ -1.10MC$ -1.63MC$ -2.44MC$ -2.11M
EBIT
C$ -1.12MC$ -1.46MC$ -1.49MC$ -2.18MC$ -2.44MC$ -2.11M
EBITDA
C$ -1.09MC$ -1.41MC$ -1.42MC$ -2.06MC$ -2.36MC$ -2.04M
Currency in CAD

NuLegacy Gold Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis